Dr. Reddy's Laboratories Limited has informed the Exchange about Action(s) taken or orders passed

Regulatory & Legal View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹1281.90

prior close

₹1283.80

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.9%-0.5% vs market

Pharmaceuticals peers, median of 158sector+1.1%-0.7% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty 100 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.5

15m

+0.7

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4+0.9-0.5+1.1-0.7

Next day

-0.1-2.4+2.3-0.5+0.3

+1.1-1.9+3.0+0.2+0.9

-2.6-4.7+2.1-3.5+0.9

-2.0-3.0+1.1-2.1+0.1

+2.0-1.3+3.4+0.0+2.0

-2.3-5.6+3.3-5.0+2.7

15d

-3.7+1.5-5.2+5.7-9.5

-4.0+4.2-8.2+8.3-12.2

+3.8+1.2+2.6+11.1-7.3

-0.8+4.1-4.9+15.5-16.3

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Reddy's Laboratories has received three orders from the Commercial Tax Department in Chennai under the Tamil Nadu GST Act, 2017, covering FY 2019-20 to FY 2021-22. The total penalty demanded is approximately ₹2.20 crore, broken down as ₹2.19 crore for FY 2019-20, ₹50,406 for FY 2020-21, and ₹4,384 for FY 2021-22. The authority held that certain supplies made by the company are taxable. The company has stated there is no material impact on its financials, operations, or other activities, and plans to file an appeal with the appellate authority.

Likely market impact

The financial impact is minor and the company has confirmed it is not material, so shareholders are unlikely to see any meaningful effect on earnings or stock price. The planned appeal could further reduce or nullify the demand.